SNP Genotyping And Analysis Market Expected To Reach $46.29 Billion By 2030 As Growth Accelerates At 20.1% CAGR
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
SNP Genotyping And Analysis Market Revenue Growth Supported By A CAGR Of 46.29% Through 2030
The market for SNP genotyping and analysis has seen explosive growth in recent years. Projections indicate an increase from $18.5 billion in 2025 to $22.24 billion in 2026, reflecting a compound annual growth rate (CAGR) of 20.2%. Historically, this expansion was driven by several factors: falling expenses associated with genetic testing, a broadening of genomics research within academia, an uptick in disease diagnostic applications, increased investment in pharmaceutical research and development, and advancements in microarray technology.
The market for SNP genotyping and analysis is projected to experience substantial expansion over the coming years. Reaching a value of $46.29 billion by 2030, it is expected to exhibit a compound annual growth rate (CAGR) of 20.1%. This anticipated growth during the forecast period is driven by factors such as the rise of personalized medicine, a greater reliance on companion diagnostics, genomic analytics empowered by artificial intelligence, the broadening scope of clinical genomics, and government-led genomic programs. Key developments shaping this period include the broadening of precision medicine applications, pharmacogenomics becoming more widely adopted, a growing dependence on cell-free DNA and liquid biopsy techniques, the emergence of high-throughput genotyping technologies, and the incorporation of AI for interpreting genetic data.
Download A Free Sample Report For Comprehensive Market Insights:
SNP Genotyping And Analysis Market Growth Drivers And Industry Catalysts
The rising prevalence of genetic disorders is anticipated to drive expansion in the SNP genotyping and analysis market moving forward. Genetic disorders are conditions stemming from abnormalities in an individual’s DNA, which can be inherited from one or both parents or result from mutations during cell division. The increasing burden of these disorders is fueled by heightened awareness and advancements in diagnostic technologies, leading to more frequent diagnoses and greater recognition of genetic conditions. SNP genotyping and analysis assist in managing genetic diseases by detecting genetic variations linked to disease risk, progression, and drug responses, facilitating early diagnosis and customized treatment strategies. For example, in February 2023, the World Health Organization, a Switzerland-based international public health agency, reported that congenital disorders were estimated to cause roughly 240,000 newborn deaths globally within the first 28 days of life annually, along with an additional 170,000 deaths among children aged 1 month to 5 years. Consequently, the growing burden of genetic diseases is propelling the growth of the SNP genotyping and analysis market.
SNP Genotyping And Analysis Market Categorization By Product Type And Application
The snp genotyping and analysis market covered in this report is segmented –
1) By Sample Type: Genomic DNA, Ribonucleic Acid (RNA), Cell-Free DNA (cfDNA), Plasma Samples, Whole Blood
2) By Technology: Microarrays And GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequemon MassArray Maldi-TOF, Other Technologies
3) By Application: Disease Diagnostics, Pharmacogenomics, Precision Medicine, Forensic Science, Agriculture And Livestock
4) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical And Biotechnological Companies, Diagnostic Laboratories, Academic And Government Institutions
Subsegments:
1) By Genomic DNA: Whole Genome Sequencing (WGS), Targeted Sequencing, Microarrays
2) By Ribonucleic Acid (RNA): RNA-Seq, Expression Profiling, Microarrays
3) By Cell-Free DNA (cfDNA): Liquid Biopsy, Non-Invasive Prenatal Testing (NIPT), Oncology Research
4) By Plasma Samples: Circulating Tumor DNA (ctDNA), Liquid Biopsy Applications, Diagnostics
5) By Whole Blood: DNA Extraction And Analysis, Blood-Based Genomic Studies, Genotyping And Molecular Diagnostics
SNP Genotyping And Analysis Market Trends Influencing Long-Term Demand
Key players within the SNP genotyping and analysis market are prioritizing innovation by creating advanced technological tools, including agricultural large-scale low-pass whole genome sequencing, specifically designed to overcome significant hurdles in molecular breeding genotyping for agricultural diploid species. This type of whole genome sequencing involves decoding the complete genetic makeup of crops or livestock, aiming to enhance essential traits such as yield, disease resistance, and adaptability to environmental conditions. For example, in June 2024, MGI Tech, a biotechnology firm based in China, introduced a comprehensive and highly efficient workflow solution tailored for agricultural large-scale low-pass whole genome sequencing (low-pass WGS). The workflow offers an automated, full-process product lineup that spans DNA extraction, library preparation, sequencing, and SNP & InDel detection, purpose-built for molecular breeding genotyping of agricultural diploid species. It is equipped with advanced automation platforms and takes advantage of MGI’s DNBSEQ-T7 and DNBSEQ-G400 sequencers, delivering ultra-high throughput along with notable flexibility. Furthermore, the solution incorporates pig reference panels and data analysis software, enabling genotyping without needing to generate custom databases.
SNP Genotyping And Analysis Market Company Landscape And Strategic Competition
Major companies operating in the snp genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International
Access The Complete SNP Genotyping And Analysis Market Report:
SNP Genotyping And Analysis Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the SNP genotyping and analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the snp genotyping and analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
